Saregama’s investment in Sanjay Leela Bhansali–promoted Bhansali Productions without acquiring film IP signals a structural ...
Measuring everything, learning nothing: Why we need to move from impact reports to impact governance
Are organisations being asked to prepare a mirage of metrics? At some point, measurement starts distorting reality. In ...
On Friday, Sen. Bernie Sanders (I-Vt) praised New Mexico's move to offer universal free child care, calling it a high-impact ...
Editorial: Tax break for new container terminal at Sparrows Point likely to prove a wise investment for County.
New research shows leaders tasked with driving engagement are feeling deeply burned out, and the youngest generation in the ...
Discover a customizable ETF rotation strategy for navigating 2026’s uncertain macro outlook. Explore diversified picks for ...
Clorox's high dividend yield provides a worthwhile incentive for investors to hold the stock while the turnaround plays out.
As of Friday, December 26, Turn Therapeutics Inc.’s TTRX share price has dipped by 5.39%, which has investors questioning if ...
As of Friday, December 26, Alterity Therapeutics Limited’s ATHE share price has dipped by 6.30%, which has investors questioning if this is right time to buy.
The "Oracle of Omaha" bought his first stock at age 11. He's offered some solid advice to young investors over the years, ...
University of Idaho receives over $6M in DoD grants to advance machine learning research for PTSD diagnosis and military ...
Before sending my kids out of the nest, I want them to understand some basic financial principles that will put them in good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback